Puma Biotechnology | La Marge Brute Sur Les Ventes



Gross Profit On Sales Changement Date
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Daiichi Sankyo JPY 424.35B 67.89B 2025-03
Exelixis USD 536.28M 10.51M 2025-04
Gilead Sciences USD 5.99B 17M 2024-12
Glaxosmithkline GBP 5.6B 94M 2024-12
Incyte USD 985.09M 111.22M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Moderna USD 17M 403M 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Takeda JPY 671.32B 55.93B 2025-03
TG Therapeutics USD 92.79M 18.25M 2024-12
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Puma Biotechnology La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.